A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome

S. Vadhan-raj, L. E. Fayad, M. A. Fanale, B. Pro, A. Rodriguez, F. B. Hagemeister, C. E. Bueso-ramos, X. Zhou, P. W. Mclaughlin, N. Fowler, J. Shah, R. Z. Orlowski, F. Samaniego, M. Wang, J. E. Cortes, A. Younes, L. W. Kwak, N. J. Sarlis, J. E. Romaguera

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Fingerprint Dive into the research topics of 'A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences